Skip to main content

Geospiza Acquires GeneSifter Microarray Software from VizX

NEW YORK (GenomeWeb News) – Geospiza has signed a definitive agreement to acquire the GeneSifter Data Analysis product from VizX Labs, the Seattle-based firm said today.
 
Geospiza said GeneSifter is a gene expression analysis platform for both microarrays and next-generation sequencing. It expects the integration of GeneSifter with its own FinchLab will be “fast and seamless.”
 
“GeneSifter will expand our market by addressing the demand for sophisticated data analysis across microarray, capillary electrophoresis, and next-generation sequencing platforms," Geospiza President Rob Arnold said in a statement.
 
Financial terms of the acquisition were not disclosed.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.